Ampliphi Biosciences Corp is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. Ampliphi Biosciences is based in Seattle, Washington and has been public since May 1994 and its stock trades on the FINRA OTC Bulletin Board under the ticker symbol APHB.PK.
AmpliPhi in the News
New technique will speed up DNA extraction
Anna spent 16 weeks in quarantine to overcome a mutant form of TB: The common diseases mutating into killers Revived Interest in Bacteriophages
June 21, 2011 – MailOnline
April 26, 2011 -- Current Biology, Volume 21, Issue 8, R267-R270
|There are currently no events scheduled.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.